Exploring the virulence potential of Staphylococcus aureus CC121 and CC152 lineages related to paediatric community-acquired bacteraemia in Manhiça, Mozambique.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
10 May 2024
Historique:
received: 19 12 2023
accepted: 05 05 2024
medline: 11 5 2024
pubmed: 11 5 2024
entrez: 10 5 2024
Statut: epublish

Résumé

Staphylococcus aureus is a frequent agent of bacteraemia. This bacterium has a variety of virulence traits that allow the establishment and maintenance of infection. This study explored the virulence profile of S. aureus strains causing paediatric bacteraemia (SAB) in Manhiça district, Mozambique. We analysed 336 S. aureus strains isolated from blood cultures of children younger than 5 years admitted to the Manhiça District Hospital between 2001 and 2019, previously characterized for antibiotic susceptibility and clonality. The strains virulence potential was evaluated by PCR detection of the Panton-Valentine leucocidin (PVL) encoding genes, lukS-PV/lukF-PV, assessment of the capacity for biofilm formation and pathogenicity assays in Galleria mellonella. The overall carriage of PVL-encoding genes was over 40%, although reaching ~ 70 to 100% in the last years (2014 to 2019), potentially linked to the emergence of CC152 lineage. Strong biofilm production was a frequent trait of CC152 strains. Representative CC152 and CC121 strains showed higher virulence potential in the G. mellonella model when compared to reference strains, with variations within and between CCs. Our results highlight the importance of monitoring the emergent CC152-MSSA-PVL

Identifiants

pubmed: 38730020
doi: 10.1038/s41598-024-61345-3
pii: 10.1038/s41598-024-61345-3
doi:

Substances chimiques

Exotoxins 0
Bacterial Toxins 0
Leukocidins 0
Virulence Factors 0
Panton-Valentine leukocidin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10758

Subventions

Organisme : Fundação para a Ciência e a Tecnologia
ID : UID/04413/2020
Organisme : Fundação para a Ciência e a Tecnologia
ID : 2022.07931.PTDC
Organisme : Fundação Calouste Gulbenkian
ID : 145278

Informations de copyright

© 2024. The Author(s).

Références

Bai, A. D. et al. Staphylococcus aureus bacteraemia mortality: A systematic review and meta-analysis. Clin. Microbiol. Infect. 28, 1076–1084. https://doi.org/10.1016/j.cmi.2022.03.015 (2022).
doi: 10.1016/j.cmi.2022.03.015 pubmed: 35339678
Otto, M. Staphylococcus aureus toxins. Curr. Opin. Microbiol. 17, 32–37. https://doi.org/10.1016/j.mib.2013.11.004 (2014).
doi: 10.1016/j.mib.2013.11.004 pubmed: 24581690
Ahmad-Mansour, N. et al. Staphylococcus aureus toxins: An update on their pathogenic properties and potential treatments. Toxins (Basel) 13, 677. https://doi.org/10.3390/toxins13100677 (2021).
doi: 10.3390/toxins13100677 pubmed: 34678970
Saeed, K. et al. Panton-Valentine leukocidin-positive Staphylococcus aureus: a position statement from the International Society of Chemotherapy. Int. J. Antimicrob. Agents. 51, 16–25. https://doi.org/10.1016/j.ijantimicag.2017.11.002 (2018).
doi: 10.1016/j.ijantimicag.2017.11.002 pubmed: 29174420
Tam, K. & Torres, V. J. Staphylococcus aureus secreted toxins and extracellular enzymes. Microbiol. Spectr. 7, 1–59. https://doi.org/10.1128/microbiolspec.GPP3-0039-2018 (2019).
doi: 10.1128/microbiolspec.GPP3-0039-2018
McGuire, E. et al. Is Panton-Valentine leucocidin (PVL) toxin associated with poor clinical outcomes in patients with community-acquired Staphylococcus aureus bacteraemia. J. Med. Microbiol. 72, 1–7. https://doi.org/10.1099/jmm.0.001683 (2023).
doi: 10.1099/jmm.0.001683
Otto, M. Staphylococcal biofilms. Microbiol. Spectr. 6, 1–26. https://doi.org/10.1128/microbiolspec.GPP3-0023-2018 (2018).
doi: 10.1128/microbiolspec.GPP3-0023-2018
Kranjec, C. et al. Staphylococcal biofilms: Challenges and novel therapeutic perspectives. Antibiotics (Basel) 10, 131. https://doi.org/10.3390/antibiotics10020131 (2021).
doi: 10.3390/antibiotics10020131 pubmed: 33573022
Sheehan, G., Dixon, A. & Kavanagh, K. Utilization of Galleria mellonella larvae to characterize the development of Staphylococcus aureus infection. Microbiology 165, 863–875. https://doi.org/10.1099/mic.0.000813 (2019).
doi: 10.1099/mic.0.000813 pubmed: 31107207
Hesketh-Best, P. J., Mouritzen, M. V., Shandley-Edwards, K., Billington, R. A. & Upton, M. Galleria mellonella larvae exhibit a weight-dependent lethal median dose when infected with methicillin-resistant Staphylococcus aureus. Pathog. Dis. 79, ftab003. https://doi.org/10.1093/femspd/ftab003 (2021).
doi: 10.1093/femspd/ftab003 pubmed: 33503238 pmcid: 8855217
Ménard, G. et al. Galleria mellonella larvae as an infection model to investigate sRNA-mediated pathogenesis in Staphylococcus aureus. Front. Cell Infect. Microbiol. 11, 631710. https://doi.org/10.3389/fcimb.2021.631710 (2021).
doi: 10.3389/fcimb.2021.631710 pubmed: 33954118 pmcid: 8089379
Andrade, M. et al. Virulence potential of biofilm-producing Staphylococcus pseudintermedius, Staphylococcus aureus and Staphylococcus coagulans causing skin infections in companion animals. Antibiotics (Basel) 11, 1339. https://doi.org/10.3390/antibiotics11101339 (2022).
doi: 10.3390/antibiotics11101339 pubmed: 36289997
Ménard, G., Rouillon, A., Cattoir, V. & Donnio, P. Y. Galleria mellonella as a suitable model of bacterial infection: Past, present and future. Front. Cell Infect. Microbiol. 11, 782733. https://doi.org/10.3389/fcimb.2021.782733 (2021).
doi: 10.3389/fcimb.2021.782733 pubmed: 35004350 pmcid: 8727906
Tsai, C. J., Loh, J. M. & Proft, T. Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing. Virulence 7, 214–229. https://doi.org/10.1080/21505594.2015.1135289 (2016).
doi: 10.1080/21505594.2015.1135289 pubmed: 26730990 pmcid: 4871635
Garrine, M. et al. Epidemiology and clinical presentation of community-acquired Staphylococcus aureus bacteraemia in children under 5 years of age admitted to the Manhiça District Hospital, Mozambique, 2001–2019. Eur. J. Clin. Microbiol. Infect. Dis. 42, 653–659. https://doi.org/10.1007/s10096-023-04580-2 (2023).
doi: 10.1007/s10096-023-04580-2 pubmed: 36932278 pmcid: 10023310
Garrine, M. et al. Antimicrobial resistance and clonality of Staphylococcus aureus causing bacteraemia in children admitted to the Manhiça District Hospital, Mozambique, over two decades. Front. Microbiol. 14, 1208131. https://doi.org/10.3389/fmicb.2023.1208131 (2023).
doi: 10.3389/fmicb.2023.1208131 pubmed: 37555065 pmcid: 10406509
Desbois, A. P. & Coote, P. J. Wax moth larva (Galleria mellonella): An in vivo model for assessing the efficacy of antistaphylococcal agents. J. Antimicrob. Chemother. 66, 1785–1790. https://doi.org/10.1093/jac/dkr198 (2011).
doi: 10.1093/jac/dkr198 pubmed: 21622972
Lawal, O. U. et al. A 6-Year update on the diversity of methicillin-resistant Staphylococcus aureus clones in Africa: A systematic review. Front. Microbiol. 13, 860436. https://doi.org/10.3389/fmicb.2022.860436 (2022).
doi: 10.3389/fmicb.2022.860436 pubmed: 35591993 pmcid: 9113548
Otto, M. Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus. Annu. Rev. Microbiol. 64, 143–162. https://doi.org/10.1146/annurev.micro.112408.134309 (2010).
doi: 10.1146/annurev.micro.112408.134309 pubmed: 20825344
He, C. et al. Leukotoxin and pyrogenic toxin superantigen gene backgrounds in bloodstream and wound Staphylococcus aureus isolates from eastern region of China. BMC Infect. Dis. 18, 395. https://doi.org/10.1186/s12879-018-3297-0 (2018).
doi: 10.1186/s12879-018-3297-0 pubmed: 30103694 pmcid: 6090790
Ruffing, U. et al. Community-associated Staphylococcus aureus from sub-saharan Africa and Germany: A cross-sectional geographic correlation study. Sci. Rep. 7, 154. https://doi.org/10.1038/s41598-017-00214-8 (2017).
doi: 10.1038/s41598-017-00214-8 pubmed: 28273954 pmcid: 5428059
Baig, S. et al. Evolution and population dynamics of clonal complex 152 community-associated methicillin-resistant Staphylococcus aureus. mSphere. 5, e00226-e320. https://doi.org/10.1128/mSphere.00226-20 (2020).
doi: 10.1128/mSphere.00226-20 pubmed: 32611695 pmcid: 7333568
Rao, Q., Shang, W., Hu, X. & Rao, X. Staphylococcus aureus ST121: A globally disseminated hypervirulent clone. J. Med. Microbiol. 64, 1462–1473. https://doi.org/10.1099/jmm.0.000185 (2015).
doi: 10.1099/jmm.0.000185 pubmed: 26445995
Sigaúque, B. et al. Community-acquired bacteremia among children admitted to a rural hospital in Mozambique. Pediatr. Infect. Dis. J. 28, 108–113. https://doi.org/10.1097/INF.0b013e318187a87d (2009).
doi: 10.1097/INF.0b013e318187a87d pubmed: 19131902
Alexopoulou, K. et al. Comparison of two commercial methods with PCR restriction fragment length polymorphism of the tuf gene in the identification of coagulase-negative staphylococci. Lett. Appl. Microbiol. 43, 450–454. https://doi.org/10.1111/j.1472-765X.2006.01964.x (2006).
doi: 10.1111/j.1472-765X.2006.01964.x pubmed: 16965378
Lina, G. et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin. Infect. Dis. 29, 1128–1132. https://doi.org/10.1086/313461 (1999).
doi: 10.1086/313461 pubmed: 10524952
Stepanović, S., Vuković, D., Dakić, I., Savić, B. & Svabic-Vlahović, M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J. Microbiol. Methods 40, 175–179. https://doi.org/10.1016/s0167-7012(00)00122-6 (2000).
doi: 10.1016/s0167-7012(00)00122-6 pubmed: 10699673
Stepanović, S. et al. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS 115, 891–899. https://doi.org/10.1111/j.1600-0463.2007.apm_630.x (2007).
doi: 10.1111/j.1600-0463.2007.apm_630.x pubmed: 17696944

Auteurs

Marcelino Garrine (M)

Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Global Health and Tropical Medicine, GHTM, Associate Laboratory in Translation and Innovation Towards Global Health, LA-REAL, Instituto de Higiene e Medicina Tropical, IHMT, Universidade NOVA de Lisboa, UNL, Rua da Junqueira 100, 1349-008, Lisbon, Portugal.

Mariana Andrade (M)

Global Health and Tropical Medicine, GHTM, Associate Laboratory in Translation and Innovation Towards Global Health, LA-REAL, Instituto de Higiene e Medicina Tropical, IHMT, Universidade NOVA de Lisboa, UNL, Rua da Junqueira 100, 1349-008, Lisbon, Portugal.

Joana Neves (J)

Global Health and Tropical Medicine, GHTM, Associate Laboratory in Translation and Innovation Towards Global Health, LA-REAL, Instituto de Higiene e Medicina Tropical, IHMT, Universidade NOVA de Lisboa, UNL, Rua da Junqueira 100, 1349-008, Lisbon, Portugal.

Inácio Mandomando (I)

Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Global Health and Tropical Medicine, GHTM, Associate Laboratory in Translation and Innovation Towards Global Health, LA-REAL, Instituto de Higiene e Medicina Tropical, IHMT, Universidade NOVA de Lisboa, UNL, Rua da Junqueira 100, 1349-008, Lisbon, Portugal.
Instituto Nacional de Saúde (INS), Ministério da Saúde, Maputo, Mozambique.
ISGlobal-Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.

Isabel Couto (I)

Global Health and Tropical Medicine, GHTM, Associate Laboratory in Translation and Innovation Towards Global Health, LA-REAL, Instituto de Higiene e Medicina Tropical, IHMT, Universidade NOVA de Lisboa, UNL, Rua da Junqueira 100, 1349-008, Lisbon, Portugal.

Sofia Santos Costa (SS)

Global Health and Tropical Medicine, GHTM, Associate Laboratory in Translation and Innovation Towards Global Health, LA-REAL, Instituto de Higiene e Medicina Tropical, IHMT, Universidade NOVA de Lisboa, UNL, Rua da Junqueira 100, 1349-008, Lisbon, Portugal. scosta@ihmt.unl.pt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH